Add BrightSurf on Google Email

Science News for January 10, 2016


Even after anti-androgen therapy, docetaxel remains useful in prostate cancer

A new study reveals that docetaxel retains effectiveness in patients with castration-resistant metastatic prostate cancer (mCRPC) treated with abiraterone. Following abiraterone, 40% of patients experienced a 50% reduction in prostate-specific antigen (PSA), demonstrating the activity of this drug sequencing.

SourceUniversity of Colorado Anschutz Medical Campus·DateJan 10, 2016
DJI Air 3 (RC-N2)

DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.

Two-stage power management system boosts energy-harvesting efficiency

A two-stage power management system developed by Georgia Tech researchers improves triboelectric generator efficiency, enabling the powering of wearable and mobile devices. The system converts fluctuating energy amplitudes to continuous direct current, increasing energy output up to 330 times.

SourceGeorgia Institute of Technology·JournalNature Communications·DateJan 10, 2016

Research raises concerns over long-term use of chromium diet pills

A recent study found that chromium supplements can partially convert into a carcinogenic form when entering cells, raising concerns over their long-term use. The research suggests that exposure to high doses of chromium may increase cancer risk, particularly for individuals taking large amounts of chromium-containing supplements.

SourceUniversity of Sydney·JournalAngewandte Chemie·DateJan 10, 2016